We are live on ! Find out more
ATXI

Avenue Therapeutics, Inc. Common Stock
ATXI

Delisted

ATXI was delisted on the 18th of March, 2025.

Back to rankings

Fund managers haven’t disclosed any holdings of ATXI yet.

ATXI Hedge Fund Activity: Q1 2025 in Review

0 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Avenue Therapeutics, Inc. Common Stock (ATXI) for Q1 2025, worth a combined $0 — down 100% from $385K a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of ATXI and 0 opened new positions — a net loss of 7 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Ikarian Capital, exiting entirely with an estimated $280K sold.

  • 0 institutional investors held Avenue Therapeutics, Inc. Common Stock (ATXI) as of Q1 2025, down from 7 in Q4 2024.
  • Funds reported $0 of Avenue Therapeutics, Inc. Common Stock stock for Q1 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Avenue Therapeutics, Inc. Common Stock positions in Q1 2025 and 7 closed out, a net change of -7 holders.
  • The largest Avenue Therapeutics, Inc. Common Stock seller in Q1 2025 was Ikarian Capital, an estimated $280K sold.

Based on aggregated 13F filings for Q1 2025.